Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Virtus LifeSci Biotech Products ETF (BBP) belongs to the Tomorrow's Treatments segment. SPDR S&P Health Care Services ETF (XHS) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. BBP is more expensive with a Total Expense Ratio (TER) of 0.79%, versus 0.35% for XHS. BBP is up 6.54% year-to-date (YTD) with +$4M in YTD flows. XHS performs worse with -1.75% YTD performance, and +$6M in YTD flows. Run a side-by-side ETF comparison of BBP and XHS below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP XHS | +3.49%-3.11% | +9.58%-3.76% | +6.54%-1.75% | +42.80%+10.69% | +83.49%+26.75% | +60.18%-0.05% |
| Flows | BBP XHS | +$4M-$8M | +$16M+$2M | +$4M+$6M | +$19M-$3M | +$19M-$34M | +$9M-$36M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP XHS | +24.65%+17.45% | +25.47%+19.20% | +23.56%+18.15% | +26.14%+21.12% |
| Max drawdown | BBP XHS | -7.42%-6.02% | -17.97%-12.54% | -25.54%-17.78% | -38.24%-32.53% |
| Max drawdown duration | BBP XHS | 32d64d | 106d128d | 292d362d | 915d1717d |
BBP | XHS | |
Last sale 3/12/2026 at 1:30 PM | $81.68 | $103.05 |
| Previous close 03/11/2026 | $84.32 | $104.90 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
BBP | XHS | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
BBP | XHS | |
|---|---|---|
| Last price | $81.68 | $103.05 |
| 1D performance | -3.13% | -1.76% |
| AuM | $50.98 M | $87.16 M |
| E/R | 0.79% | 0.35% |
BBP | XHS | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | VIRTUS Investment Partners | SPDR |
| Benchmark | LifeSci Biotechnology Products Index | S&P Health Care Services Select Industry Index |
| N° of holdings | 58 | 52 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | September 28, 2011 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
